Market research future will be publishing a cooked research report on “Global Fluoroscopy and Mobile C-Arms Market” that contains the information from 2015 to 2023. The global fluoroscopy and mobile c-arms market is expected to register at a CAGR 4.58% during the forecast period of 2018–2023
Market Research Future (MRFR) recognizes the following companies as the key players in the global fluoroscopy and c-arms market that includes Allengers Medical Systems (India), Canon Medical Systems Corporation (Japan), DMS Group (France), GE Healthcare (US), Hitachi Ltd (Tokyo), Hologic Inc. (US), Omega Medical Imaging, LLC (US), OrthoScan, Inc. (US), Koninklijke Philips N.V. (The Netherlands), Shimadzu Corporation (Japan), Siemens (Germany), Varian Medical Systems, Inc. (US), Villa Sistemi Medicali Spa (Italy), and Ziehm Imaging GmbH (US).
The rising prevalence of chronic diseases, growing geriatric population, and rising adoption of fluoroscopy in orthopedic and neurological procedures are some factors propelling the growth of the market. Despite the drivers, the high cost associated with fluoroscopic and mobile c-arm systems, the risk of radiation exposure, and presence of substitutes are some factors that are likely to hinder the growth of the market over the assessment period.
The global fluoroscopy and mobile c-arms market has been segmented into device type, application, and end user. On the basis of device type, the global fluoroscopy and mobile c-arms market has been segmented into fluoroscopy systems and mobile c-arms. Based on application, the market has been segmented into gastrointestinal, orthopedics, pain management and trauma, cardiovascular, neurology, urology, and others. By end user, the market has been segmented into hospital and clinics, diagnostic centers, research and academic institutes, and others. The hospital and clinics segment is accounted for a market value of USD 895.96 million in 2017.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/fluoroscopy-mobile-c-arms-market-7717
Geographically, the Americas is expected to dominate the global fluoroscopy and mobile c-arms market. In this region, North America is expected to dominate the market owing to the acceptance of new and innovative products, the growth in awareness about medical imaging devices, and growing financial capability to purchase expensive machines. Europe showed a significant amount of growth in the market due to the rising incidences of road accidents leading to the increasing number of orthopedic surgeries in the European region, increased expenditure in the healthcare sector, and growing R&D activities. Asia-Pacific is estimated to be the fastest growing region in the market. The developing economies of China, India, and South Korea are emerging as major destinations for outsourcing clinical trials and pathology testing. According to MRFR Analysis, China accounted for about 19.6% share in the Asia-Pacific region in 2017. Furthermore, the Middle East & Africa has the least share of the global fluoroscopy and mobile c-arms market due to the low disposable income and poor healthcare infrastructure.
Key Findings of the Study